<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940324-2-00095</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. What measurable changes have occurred as a result of the combination of intervention strategies regarding the number of new users in the target population, compared to the control/comparison group, for each of the following substances: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Alcoholic beverages; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;All types of tobacco products; and <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Other drugs such as marijuana, cocaine, crack/cocaine, inhalants, steroids, heroin, etc.? <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. What measurable changes have occurred as a result of the combination of intervention strategies regarding the number of users in the target population, compared to the control/comparison group, who have used each of the following substances in the past month: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> &bull;Alcoholic beverages;  <!-- PJG 0012 frnewline --> &bull;All types of tobacco products; and  <!-- PJG 0012 frnewline --> &bull;Other drugs such as marijuana, cocaine, crack/cocaine, steroids, inhalants, heroin, etc.? <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. What measurable changes have occurred as a result of the combination of intervention strategies regarding the amount of regular use of alcoholic beverages, all types of tobacco products, and other drugs such as marijuana, cocaine, crack/cocaine, steroids, inhalants, heroin, etc., by the users in the target population, as compared to the control/comparison group? <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4. What measurable changes have occurred as a result of the combination of intervention strategies regarding the numbers of the target population compared to the control/comparison group, who disapprove of the use of alcoholic beverages, tobacco products, and other drug use?  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5. What measurable changes have occurred as a result of the combination of intervention strategies regarding participants' and control/comparison groups' perceptions of harm associated with ATOD use?  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 6. What measurable changes have occurred as a result of the combination of intervention strategies regarding the target population's, compared to the control/comparison group's, self-reported involvement in physical fighting, victimization, assault injuries, aggressive behavior, carrying and usage of weapons, and activities that bring youth in contact with the juvenile/criminal justice system?  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Grantees will be required to collect uniform baseline and yearly data on some indicators using standardized instruments common to all grantees. Details regarding the specific instruments, data collection and analysis, aggregation to group, and procedures for transmitting the results to CSAP will be provided at the first grantee meeting following award. OMB clearance will be obtained for these instruments.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Substance abuse and related problems have frequently been measured through surveys and archival indicator data. CSAP encourages applicants to make use of such available data in their communities, such as crime statistics and Drug Abuse Warning Network (DAWN) data.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> CSAP Cross-Site Evaluation:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In addition to the requirement for individual project evaluation, CSAP is planning to conduct a cross-site evaluation of the High Risk Youth Demonstration Grant Program. All applicants must provide written assurance that they will cooperate fully in the conduct of the cross-site evaluation.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Review Process:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Applications accepted for review will be assigned, at the central receipt point (Division of Research Grants, NIH), to an Initial Review Group (IRG) composed primarily of non-Federal experts. Applications will be reviewed by the IRG for technical merit in accordance with established PHS/SAMHSA peer review procedures for grants. Notification of the IRG's recommendation will be sent to the applicant upon completion of the initial review. In addition, the IRG recommendations on the technical merit of applications will undergo a second level of review by the appropriate advisory council, whose review may be based on policy considerations as well as technical merit. Applications may be considered for funding only if the advisory council concurs with the IRG's recommendation for approval.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            